Roche Holding AG (CHIX:ROZ) OCF Yield %: 7.39 (As of Jun. 27, 2026) — Near Median


CHIX:ROZ Roche Holding AG CHIX:ROZ
77 GF Score
Price CHF340.60
GF Value CHF271.62
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Roche Holding AG OCF Yield %?

Roche Holding AG CHIX:ROZ -0.70% 77 OCF Yield % is 7.39 as of Jun. 27, 2026, which is 6% below its 10-year median of 7.86. GuruFocus rates CHIX:ROZ with a GF Score™ of 77/100 and a GF Value™ of CHF271.62 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Roche Holding AG ranks better than 70.15% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Roche Holding AG's Trailing 12-Month Cash Flow from Operations is CHF18,852 Mil, and Market Cap is CHF267,968 Mil. Therefore, Roche Holding AG's OCF Yield % for today is 7.39%.

The historical rank and industry rank for Roche Holding AG's OCF Yield % or its related term are showing as below:

CHIX:ROz' s OCF Yield % Range Over the Past 10 Years
Min: 5.66   Med: 7.86   Max: 10.28
Current: 7.39


During the past 13 years, the highest OCF Yield % of Roche Holding AG was 10.28%. The lowest was 5.66%. And the median was 7.86%.

CHIX:ROz's OCF Yield % is ranked better than
70.15% of 1005 companies
in the Drug Manufacturers industry
Industry Median: 3.61 vs CHIX:ROz: 7.39

Roche Holding AG's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Roche Holding AG OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Roche Holding AG OCF Yield % Related Terms


Roche Holding AG OCF Yield % Historical Data

* Premium members only.

The historical data trend for Roche Holding AG's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG OCF Yield % Chart

Roche Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.59 8.15 7.75 9.36 7.04

Roche Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.90 7.24 11.35 6.47 8.77

CHIX:ROZ vs LLY, JNJ, ABBV: OCF Yield % Comparison

For the Drug Manufacturers - General subindustry, Roche Holding AG's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roche Holding AG OCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's OCF Yield % falls into.


CHIX:ROZ
77GF Score
Roche Holding AG CHIX:ROZ
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roche Holding AG OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Roche Holding AG's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=18852 / 267964.1424
=7.04%

Roche Holding AG's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=11752 * 2 / 267964.1424
=8.77%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 7.39 mean?
Roche Holding AG (CHIX:ROZ) has a OCF Yield % of 7.39 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Roche Holding AG and its competitors. This is near median its historical median of 7.86. Over the past decade, Roche Holding AG's OCF Yield % has ranged from 5.66 to 10.28. According to the industry distribution chart, Roche Holding AG ranks #300 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 29.9%.
Is Roche Holding AG's OCF Yield % too high?
Roche Holding AG's current OCF Yield % of 7.39 is near median its 10-year median of 7.86. Over the past 10 years, this metric has ranged from a low of 5.66 to a high of 10.28. The Drug Manufacturers industry median OCF Yield % is 3.61. Roche Holding AG's value of 7.39 is 104.7% above this industry median. Based on the distribution chart, Roche Holding AG ranks #300 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Roche Holding AG has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Roche Holding AG's OCF Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Roche Holding AG ranks #300 out of 1005 companies for OCF Yield %. This puts Roche Holding AG in the upper half of its industry. The industry median OCF Yield % is 3.61. Roche Holding AG's value of 7.39 is 104.7% above this benchmark. Historically, Roche Holding AG's own OCF Yield % has ranged from 5.66 to 10.28 over the past decade. While the company's 10-year median is 7.86 vs. the industry median of 3.61, Roche Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Roche Holding AG's current OCF Yield % of 7.39 is 104.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Roche Holding AG and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Roche Holding AG's current OCF Yield % is 7.39, which is near median its own 10-year median of 7.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roche Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Roche Holding AG (CHIX:ROZ) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF271.62, compared to a current price of CHF340.60 — trading 25.4% above its estimated fair value. The current OCF Yield % is 7.39, which is near median its 10-year median of 7.86 and 104.7% above the Drug Manufacturers industry median of 3.61. Roche Holding AG's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Roche Holding AG (CHIX:ROZ), the current OCF Yield % is 7.39 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Roche Holding AG (CHIX:ROZ) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of CHF340.60 is trading 25.4% above its estimated GF Value™ of CHF271.62. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for CHIX:ROZ:

  • OCF Yield %: 7.39 (near median its 10-year median of 7.86)
  • GF Value™: CHF271.62 vs. price of CHF340.60 (25.4% above fair value)
  • GF Score™: 77/100 with 3 warning signs
  • Industry Position: 104.7% above the Drug Manufacturers median (#300 of 1005)

No single metric tells the full story. See the CHIX:ROZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
77GF Score

Get the complete analysis for CHIX:ROZ

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF340.60
Price
CHF271.62
GF Value